FindTrial
Sign In

study on effect of naturopathy and yoga therapy on in improving psychological profile" in patients of metabolic syndrome

Effects of yoga and naturopathy intervention on Alexythymia and negative emotions in subjects with metabolic syndrome.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/03/001654
Enrollment
30
Registered
2011-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Metabolic syndrome

Interventions

Intervention1: Yoga and Nature-cure interventions: 21 days Inpatient Naturopathy and yoga based lifestyle interventiona Intervention2: Nature cure and yoga intervention along with glutathione rich di

Sponsors

INYSMRS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male or Female Subjects aged 18-70 years of age Subjects Diagnosed of Metabolic syndrome as per ATPIII criteria Subjects willing to take residential treatment for minimum 21 days.

Exclusion criteria

Exclusion criteria: Patients not willing to give consent for the study. H/o CAD, Angina, TMT positive for inducible ischemia. Those suffering from Renal Calculi or had a history of renal calculi in past with oxalate or phytate calculi. Uncontrolled hypertension SBP200mmhg, DBP100 mmhg Uncontrolled diabetes () with or without diabetic nephropathy or microalbuminuria + ve. Those who are on parental insulin, statins etc. Patients taking other therapies such as homeopathy / ayurveda etc which can have direct or indirect effect on study variables. Abnormal RFT as defined by BUN, S Creatinine 1.2, S Uric acid , Pregnancy / Lactation, Those with Hypothyroidism, Cushing?s syndrome, pheochromocytoma. Intake of steroids / HRT Those who are regularly practicing yoga for last three months Those with Major psychiatric illness with cognitive impairments. Those with known COPD, Congenital heart defects.

Design outcomes

Primary

MeasureTime frame
1. Reduction in Alexythymia- Toronto Alexythymia Scale. 2. Reductions in anger, hostility, anxiety and depression in SCL90 Timepoint: Baseline and post intervention (day 21)—

Secondary

MeasureTime frame
1. Fasting Lipid Profile (TC,LDL-C,HDL-C, VLDL, Triglycerides) 2. Systolic and Diastolic Blood pressure 3. Fasting and post prandial blood glucose 4. Anthropometry :Waist Circumference, Hip circumference, W:H ratio, BMI 5. Body composition analysis 6. Serum Insulin 7. CRP 8. Platelet aggregation factor 9. Glutathione peroxides, Glutathione Synthase, glutathione reductase 10. Framingham risk reduction. Timepoint: Baseline and post intervention (day 21)—

Countries

India

Contacts

Public ContactDrAvinash Kadam
CMO@jindalnaturecure.org

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026